{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:54:08Z","timestamp":1781589248877,"version":"3.54.5"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The emergence of shigellosis caused by\n                      <jats:italic>Shigella<\/jats:italic>\n                      spp. poses a significant threat to global health, and the prevalence of multidrug-resistant (MDR) strains necessitates the development of effective antimicrobial therapies. Bacteriophages present a promising approach for both prevention and treatment of MDR infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Ten lytic bacteriophages targeting\n                      <jats:italic>Shigella flexneri<\/jats:italic>\n                      2457T were isolated from wastewater using the double-layer agar method. Phage morphology, lytic activity spectrum, latent period, burst size, bacterial killing efficiency, and efficacy under ex vivo microbiota conditions were evaluated. Transmission electron microscopy, one-step growth assays, bacterial killing assays, anaerobic fecal slurry co-culture experiments, and whole-genome sequencing of the representative phage PSW32 were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transmission electron microscopy revealed that these phages possessed icosahedral heads and contractile tails, consistent with myovirus-like morphology commonly observed among tailed bacteriophages within the class\n                      <jats:italic>Caudoviricetes<\/jats:italic>\n                      . Most phages exhibited broad lytic activity against\n                      <jats:italic>S. flexneri, S.\u00a0sonnei<\/jats:italic>\n                      , and\n                      <jats:italic>S. dysenteriae<\/jats:italic>\n                      , with limited activity against\n                      <jats:italic>S. boydii<\/jats:italic>\n                      in spot assay. Among them, phages PSW32, PSW37, PSW38, and PSW40 exhibited lytic activity against the largest number of tested\n                      <jats:italic>Shigella<\/jats:italic>\n                      strains under the spot assay conditions. One-step growth assays revealed latent periods of 30-70 minutes and burst sizes of 40-267 PFU\/cell, indicating efficient host infection activity. At multiplicities of infection (MOIs) ranging from 10 to 0.001, all phages efficiently suppressed the growth of\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      . Based on their lytic kinetics and host range, PSW32 and PSW40 were further evaluated in an ex vivo microbiota model using anaerobic fecal slurry co-cultures. PSW32 reduced CFUs by 88% at 2 h and decreased bacterial levels to below the limit of detection (LOD) by 3 h. PSW40 reduced CFUs by 69% at 2 h and reduced bacterial levels to below the limit of detection (LOD) by 3 h. Genomic analysis of PSW32 identified a T4-like lytic architecture with no detectable genes linked to antimicrobial resistance or virulence, supporting its potential applicability for further evaluation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      These newly isolated lytic phages exhibited rapid bacterial activity under both\n                      <jats:italic>in vitro<\/jats:italic>\n                      and\n                      <jats:italic>ex vivo<\/jats:italic>\n                      microbiota-associated conditions and broad lytic activity against multiple\n                      <jats:italic>Shigella<\/jats:italic>\n                      species, Collectively, the findings support their potential for further investigation as phage-based strategies for controlling\n                      <jats:italic>Shigella<\/jats:italic>\n                      infections and contamination.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1837303","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:38:43Z","timestamp":1781588323000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolation and characterization of lytic Shigella bacteriophages with rapid in vitro and ex vivo bactericidal activity"],"prefix":"10.3389","volume":"16","author":[{"given":"Nida","family":"Shaheen","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine, Ohio University","place":["Athens, OH, United States"]},{"name":"Infectious and Tropical Disease Institute, Ohio University","place":["Athens, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maranda","family":"Stricklin","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Virginia Polytechnic and State University","place":["Blacksburg, VA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kordesch","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy, Ohio University","place":["Athens, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Ohio University Heritage College of Osteopathic Medicine, Ohio University","place":["Athens, OH, United States"]},{"name":"Infectious and Tropical Disease Institute, Ohio University","place":["Athens, OH, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00705-006-0849-1","article-title":"5500 phages examined in the electron microscope","volume":"152","author":"Ackermann","year":"2007","journal-title":"Arch. Virol."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.5962\/bhl.title.6966","article-title":"Bacteriophages","volume-title":"Wiley interscience","author":"Adams","year":"1959"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01876","article-title":"Genomic and proteomic characterizations of Sfin-1, a novel lytic phage infecting multidrug-resistant Shigella spp. and Escherichia coli C","volume":"10","author":"Ahamed","year":"2019","journal-title":"Front. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1240570","article-title":"Characterizations of novel broad-spectrum lytic bacteriophages Sfin-2 and Sfin-6 infecting MDR Shigella spp. with their application on raw chicken to reduce the Shigella load","volume":"14","author":"Ahamed","year":"2023","journal-title":"Front. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3791\/59524","article-title":"An in vitro batch-culture model to estimate the effects of interventional regimens on human fecal microbiota","author":"Ahmadi","year":"2019","journal-title":"J. Visualized Experiments: JoVE"},{"key":"B6","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1038\/s41598-024-57423-1","article-title":"Multidrug-resistant conjugative plasmid carrying mphA confers increased antimicrobial resistance in Shigella","volume":"14","author":"Asad","year":"2024","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102533","article-title":"Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh","volume":"9","author":"Azmi","year":"2014","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12879-024-09066-w","article-title":"Prevalence, antimicrobial susceptibility test and associated factors of Salmonella and Shigella in ready-to-eat fruit juices and salads in Mekelle, Northern Ethiopia","volume":"24","author":"Berihu","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.3201\/eid2209.160624","article-title":"Elevated risk for antimicrobial drug\u2013resistant Shigella infection among men who have sex with men, United States 2011\u20132015 - volume 22, number 9\u2014September 2016 - emerging infectious diseases journal - CDC","volume":"22","author":"Bowen","year":"2016","journal-title":"Emerging Infect. Dis"},{"key":"B10","article-title":"Clinical overview of Shigellosis","volume-title":"Shigella - shigellosis","year":"2024"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S1473-3099(22)00370-X","article-title":"Outbreak of sexually transmitted, extensively drug-resistant Shigella sonnei in the UK 2021-22: a descriptive epidemiological study","volume":"22","author":"Charles","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fm.2024.104641","article-title":"Development and application of a bacteriophage cocktail for Shigella flexneri biofilm inhibition on the stainless steel surface","volume":"125","author":"Choi","year":"2025","journal-title":"Food Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106538","article-title":"Isolation, genomic characterization of Shigella prophage fPSFA that effectively infects multi-drug resistant Shigella isolates from the Indian poultry sector","volume":"188","author":"Choudhary","year":"2024","journal-title":"Microb. Pathogen."},{"key":"B14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/82_2021_248","article-title":"Shigella-controlled human infection models: current and future perspectives","volume":"445","author":"Clarkson","year":"2024","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"B16","article-title":"CDC yellow book 2024: health information for international travel","volume-title":"CDC yellow book 2024: health information for international travel","author":"Nemhauser","year":"2023"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4682172\/v1","article-title":"Multidrug-resistant Shigella flexneri outbreak associated with a high-mortality spillover event into nonhuman primates","author":"Domman","year":"2024","journal-title":"Res. Square"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/2007\/976850","article-title":"Phage as an antimicrobial agent: D\u2019Herelle\u2019s heretical theories and their role in the decline of phage prophylaxis in the West","volume":"18","author":"Fruciano","year":"2007","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1555220","article-title":"Non-invasive treatment of Clostridioides difficile infection with a human-origin probiotic cocktail through gut microbiome-gut metabolome modulations","volume":"16","author":"Gurung","year":"2025","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001923","article-title":"World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010","volume":"12","author":"Havelaar","year":"2015","journal-title":"PloS Med."},{"key":"B21","unstructured":"Health alert network (HAN) - 00486 | Increase in extensively drug-resistant shigellosis in the United States"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S0140-6736(25)01033-5","article-title":"Shigellosis","volume":"406","author":"Hendrick","year":"2025","journal-title":"Lancet"},{"key":"B23","first-page":"329","article-title":"Bacteriophage as a treatment in acute medical and surgical infections","volume":"7","author":"Herelle","year":"1931","journal-title":"Bull. N. Y. Acad. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.resmic.2013.08.007","article-title":"Characterization and complete genome sequence of the Shigella bacteriophage pSf-1","volume":"164","author":"Jun","year":"2013","journal-title":"Res. Microbiol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118557","article-title":"Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy","volume":"10","author":"Khan Mirzaei","year":"2015","journal-title":"PloS One"},{"key":"B26","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull. World Health Organ."},{"key":"B27","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","article-title":"Shigellosis","volume":"391","author":"Kotloff","year":"2018","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41467-023-36222-8","article-title":"Rapid emergence of extensively drug-resistant Shigella sonnei in France","volume":"14","author":"Lef\u00e8vre","year":"2023","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/MPG.0000000000002203","article-title":"Bacteriophage therapy testing against Shigella flexneri in a novel human intestinal organoid-derived infection model","volume":"68","author":"Llanos-Chea","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"19313","DOI":"10.1038\/s41598-021-98910-z","article-title":"Morphological, biological, and genomic characterization of a newly isolated lytic phage Sfk20 infecting Shigella flexneri, Shigella sonnei, and Shigella dysenteriae1","volume":"11","author":"Mallick","year":"2021","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2024.114951","article-title":"A simplified method of bacteriophage preparation for transmission electron microscope","volume":"328","author":"Meidaninikjeh","year":"2024","journal-title":"J. Virological Methods"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004944","article-title":"Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials","volume":"4","author":"Merabishvili","year":"2009","journal-title":"PloS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s44298-025-00155-4","article-title":"Therapeutic potential of Shigella phage SSG23 against Shigella sonnei biofilms and in BALB\/c mice","volume":"3","author":"Mondal","year":"2025","journal-title":"NPJ Viruses"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.cell.2017.10.045","article-title":"Contemporary phage biology: from classic models to new insights","volume":"172","author":"Ofir","year":"2018","journal-title":"Cell."},{"key":"B35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41598-021-04484-1","article-title":"Development of high-resolution melting (HRM) assay to differentiate the species of Shigella isolates from stool and food samples","volume":"12","author":"Pakbin","year":"2022","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032448","article-title":"Molecular mechanisms of Shigella pathogenesis; recent advances","volume":"24","author":"Pakbin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1002\/fsn3.2603","article-title":"Genetic diversity and antibiotic resistance of Shigella spp. isolates from food products","volume":"9","author":"Pakbin","year":"2021","journal-title":"Food. Sci. Nutr."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/idr16060092","article-title":"Advancing phage therapy: a comprehensive review of the safety, efficacy, and future prospects for the targeted treatment of bacterial infections","volume":"16","author":"Palma","year":"2024","journal-title":"Infect. Dis. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1007\/s00253-019-10039-2","article-title":"Silviavirus phage \u03d5MR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin","volume":"103","author":"Peng","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B40","unstructured":"Phage DNA isolation kit | Norgen biotek corp"},{"key":"B41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jiph.2017.09.025","article-title":"Emergence of antibiotic resistant Shigella species: a matter of concern","volume":"11","author":"Puzari","year":"2018","journal-title":"J. Infection Public Health"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.2147\/IDR.S219755","article-title":"Shigella: antibiotic-resistance mechanisms and new horizons for treatment","volume":"12","author":"Ranjbar","year":"2019","journal-title":"Infection Drug Resistance"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2023.65","article-title":"Shigella flexneri serotypes: O-antigen structure, serotype conversion, and serotyping methods","volume":"38","author":"Sadredinamin","year":"2023","journal-title":"Oman Med. J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1038\/s41598-023-29637-2","article-title":"Effect of in vitro cultivation on human gut microbiota composition using 16S rDNA amplicon sequencing and metabolomics approach","volume":"13","author":"Srednicka","year":"2023","journal-title":"Sci. Rep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-virology-010320-052547","article-title":"Ecology, structure, and evolution of Shigella phages","volume":"7","author":"Subramanian","year":"2020","journal-title":"Annu. Rev. Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(01)20383-3","article-title":"An investigation on the nature of ultra-microscopic viruses","volume":"186","author":"Twort","year":"1915","journal-title":"Lancet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01821-23","article-title":"How to introduce a new bacteriophage on the block: a short guide to phage classification","volume":"98","author":"Valencia-Toxqui","year":"2024","journal-title":"J. Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijfoodmicro.2009.10.024","article-title":"Isolation and characterization of a novel virulent phage (phiLdb) of Lactobacillus delbrueckii","volume":"137","author":"Wang","year":"2010","journal-title":"Int. J. Food Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1080\/20469047.2017.1409454","article-title":"Guidelines for the treatment of dysentery (Shigellosis): a systematic review of the evidence","volume":"38","author":"Williams","year":"2018","journal-title":"Paediatrics Int. Child Health"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03188-20","article-title":"Genomic drivers of multidrug-resistant Shigella affecting vulnerable patient populations in the United States and abroad","volume":"12","author":"Worley","year":"2021","journal-title":"mBio"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00259","article-title":"Isolation and characterization of the novel phages vB_VpS_BA3 and vB_VpS_CA8 for lysing Vibrio parahaemolyticus","volume":"11","author":"Yang","year":"2020","journal-title":"Front. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.03027","article-title":"Characterization and genomic analysis of SFPH2, a novel T7virus infecting Shigella","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13099-025-00735-y","article-title":"Recent insights on challenges encountered with phage therapy against gastrointestinal-associated infections","volume":"17","author":"Youssef","year":"2025","journal-title":"Gut Pathog."},{"key":"B54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40475-014-0019-6","article-title":"Shigella: a highly virulent and elusive pathogen","volume":"1","author":"Zaidi","year":"2014","journal-title":"Curr. Trop. Med. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3382\/ps.2011-02037","article-title":"Phage inactivation of foodborne Shigella on ready-to-eat spiced chicken","volume":"92","author":"Zhang","year":"2013","journal-title":"Poult. Sci."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1499325","article-title":"Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs","volume":"14","author":"Zhao","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/s43014-023-00193-6","article-title":"Characterization and genomic analysis of a novel E. coli lytic phage with extended lytic activity against S. enteridis and S. typhimurium","volume":"6","author":"Zhong","year":"2024","journal-title":"Food Prod. Process. Nutr."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1837303\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:38:47Z","timestamp":1781588327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1837303\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":57,"alternative-id":["10.3389\/fcimb.2026.1837303"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1837303","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"article-number":"1837303"}}